Pharmaceutical Preparations · A8 · CIK 1408443
Develops and commercializes innovative cardiovascular medicines, including the self-administered nasal spray CARDAMYST for PSVT
Comparable business profile · signals at a glance
In the 90 days to Jan 26, 2026: 5 sold $1.1M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 26, 2026 | Oliveto JosephPresident and CEO | Sell | 34,523 | $1.93 | $67K |
| Jan 26, 2026 | Bharucha DavidChief Medical Officer | Sell | 12,245 | $1.93 | $24K |
| Jan 26, 2026 | Nelson Jeffrey EdwardChief Operating Officer | Sell | 12,245 | $1.93 | $24K |
| Jan 26, 2026 | Hasija AmitCFO & EVP of Corp. Development | Sell | 12,245 | $1.93 | $24K |
| Jan 26, 2026 | Muller LorenzChief Commercial Officer | Sell | 11,180 | $1.93 | $22K |
| Jan 8, 2026 | Oliveto JosephPresident and CEO | Sell | 43,000 | $2.25 | $97K |
| Jan 7, 2026 | Oliveto JosephPresident and CEO | Sell | 500 | $2.25 | $1K |
| Dec 15, 2025 | Oliveto JosephPresident and CEO | Sell | 133,054 | $2.32 | $309K |
| Dec 15, 2025 | Bharucha DavidChief Medical Officer | Sell | 58,007 | $2.32 | $135K |
| Dec 15, 2025 | Hasija AmitCFO & EVP of Corp. Development | Sell | 58,007 | $2.32 | $135K |
| Dec 15, 2025 | Nelson Jeffrey EdwardChief Operating Officer | Sell | 58,007 | $2.32 | $135K |
| Dec 15, 2025 | Muller LorenzChief Commercial Officer | Sell | 53,566 | $2.32 | $124K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.